Theradiag SA
Research Theradiag SA (ALTHE) on Bullrun: market cap EUR 47.30M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALTHE
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 47.30M
- Financial periodFY2025
- RevenueEUR 1.19M
- Revenue growth42.9%
- Net income-EUR 5.69M
- Free cash flow-EUR 7.16M
- Gross margin-240.8%
Valuation Snapshot
latest market cap is EUR 47.30M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 1.19M | -EUR 5.69M | -EUR 7.16M | -240.8% | -0.09 | EUR 1.88M | EUR 4.94M | -EUR 2.59M |
| FY2024 | EUR 830.21K | -EUR 5.76M | -EUR 3.01M | -346.0% | -0.12 | EUR 4.17M | EUR 1.30M | -EUR 114 |
| FY2023 | EUR 1.82M | -EUR 3.68M | -EUR 2.60M | -59.3% | -0.08 | EUR 7.82M | EUR 1.95M | EUR 5.65M |
| FY2022 | EUR 1.24M | -EUR 4.96M | -EUR 5.59M | -246.9% | -0.17 | EUR 2.49M | EUR 2.51M | EUR 544.87K |
| FY2021 | EUR 1.48M | -EUR 3.76M | -EUR 4.03M | -154.2% | n/a | EUR 2.46M | EUR 2.94M | -EUR 1.27M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 47.30M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Theradiag SA
Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Theradiag SA's market cap?
Theradiag SA's market capitalization is EUR 47.30M.
What does Theradiag SA do?
Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.